Anisur Rahman

Summary

Affiliation: University College London
Country: UK

Publications

  1. pmc PEGylated drugs in rheumatology--why develop them and do they work?
    Thomas McDonnell
    Centre for Rheumatology Research, Division of Medicine, University College London, Room 412 Rayne Institute, 5 University Street, London WC1E 6JF, UK
    Rheumatology (Oxford) 53:391-6. 2014
  2. pmc British pain clinic practitioners' recognition and use of the bio-psychosocial pain management model for patients when physical interventions are ineffective or inappropriate: results of a qualitative study
    Geoffrey Harding
    Peninsula Medical School Primary Care, Smeall Building, St Luke s Campus, Exeter, UK
    BMC Musculoskelet Disord 11:51. 2010
  3. ncbi request reprint The importance of somatic mutations in the V(lambda) gene 2a2 in human monoclonal anti-DNA antibodies
    A Rahman
    Center for Rheumatology Bloomsbury Rheumatology Unit, Division of Medicine, University College, London, UK
    J Mol Biol 307:149-60. 2001
  4. doi request reprint Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases
    A Rahman
    Division of Medicine, Centre for Rheumatology, University College London, London, UK
    Lupus 17:232-5. 2008
  5. doi request reprint Factors affecting self-efficacy and pain intensity in patients with chronic musculoskeletal pain seen in a specialist rheumatology pain clinic
    A Rahman
    Centre for Rheumatology Research, Room 331, Windeyer Institute, 46 Cleveland Street, London W1T 4JF, UK
    Rheumatology (Oxford) 47:1803-8. 2008
  6. ncbi request reprint Autoantibodies, lupus and the science of sabotage
    A Rahman
    Centre for Rheumatology, Department of Medicine, University College London, Arthur Stanley House, 40 50 Tottenham Street, W1T 4NJ, UK
    Rheumatology (Oxford) 43:1326-36. 2004
  7. ncbi request reprint Important determinants of self-efficacy in patients with chronic musculoskeletal pain
    Anisur Rahman
    Centre for Rheumatology, University College London, London, UK
    J Rheumatol 31:1187-92. 2004
  8. ncbi request reprint Structure and function of autoantibodies and their role in autoimmune rheumatic diseases
    Anisur Rahman
    Centre for Rheumatology, Division of Medicine, University College, Centre for Rheumatology ResearchRoom 118, 1st Floor, Windeyer Institute, 46 Cleveland Street, London W1T 4JF UK
    Expert Rev Clin Immunol 2:225-36. 2006
  9. ncbi request reprint Anti-DNA antibodies--overview of assays and clinical correlations
    A Rahman
    Centre for Rheumatology, Department of Medicine, University College London, London, UK
    Lupus 11:770-3. 2002
  10. pmc Cytokines in systemic lupus erythematosus, London, UK
    Anisur Rahman
    Centre for Rheumatology, Department of Medicine, University College London, London, UK
    Arthritis Res Ther 5:160-4. 2003

Collaborators

Detail Information

Publications57

  1. pmc PEGylated drugs in rheumatology--why develop them and do they work?
    Thomas McDonnell
    Centre for Rheumatology Research, Division of Medicine, University College London, Room 412 Rayne Institute, 5 University Street, London WC1E 6JF, UK
    Rheumatology (Oxford) 53:391-6. 2014
    ..This review focuses on the currently available PEGylated drugs used in rheumatological diseases, their efficacy, drawbacks and the current clinical trial evidence supporting their use. ..
  2. pmc British pain clinic practitioners' recognition and use of the bio-psychosocial pain management model for patients when physical interventions are ineffective or inappropriate: results of a qualitative study
    Geoffrey Harding
    Peninsula Medical School Primary Care, Smeall Building, St Luke s Campus, Exeter, UK
    BMC Musculoskelet Disord 11:51. 2010
    ..To explore how chronic musculoskeletal pain is managed in multidisciplinary pain clinics for patients for whom physical interventions are inappropriate or ineffective...
  3. ncbi request reprint The importance of somatic mutations in the V(lambda) gene 2a2 in human monoclonal anti-DNA antibodies
    A Rahman
    Center for Rheumatology Bloomsbury Rheumatology Unit, Division of Medicine, University College, London, UK
    J Mol Biol 307:149-60. 2001
    ..In a third light chain, however, mutation to arginine at a different site blocked binding to DNA...
  4. doi request reprint Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases
    A Rahman
    Division of Medicine, Centre for Rheumatology, University College London, London, UK
    Lupus 17:232-5. 2008
  5. doi request reprint Factors affecting self-efficacy and pain intensity in patients with chronic musculoskeletal pain seen in a specialist rheumatology pain clinic
    A Rahman
    Centre for Rheumatology Research, Room 331, Windeyer Institute, 46 Cleveland Street, London W1T 4JF, UK
    Rheumatology (Oxford) 47:1803-8. 2008
    ..We studied 354 patients referred to a rheumatology chronic pain clinic over 5 yrs to identify factors affecting their self-efficacy and intensity of pain...
  6. ncbi request reprint Autoantibodies, lupus and the science of sabotage
    A Rahman
    Centre for Rheumatology, Department of Medicine, University College London, Arthur Stanley House, 40 50 Tottenham Street, W1T 4NJ, UK
    Rheumatology (Oxford) 43:1326-36. 2004
    ..The heavy chain of the pathogenic APL antibody IS4 contains four exposed arginines in CDR3. The results of mutagenesis studies suggested that two of these promote binding to cardiolipin whereas the other two have no such effect...
  7. ncbi request reprint Important determinants of self-efficacy in patients with chronic musculoskeletal pain
    Anisur Rahman
    Centre for Rheumatology, University College London, London, UK
    J Rheumatol 31:1187-92. 2004
    ..To define the presenting characteristics of a population of patients with chronic musculoskeletal pain seen in a tertiary rheumatology clinic, and to investigate which factors are associated with self-efficacy in these patients...
  8. ncbi request reprint Structure and function of autoantibodies and their role in autoimmune rheumatic diseases
    Anisur Rahman
    Centre for Rheumatology, Division of Medicine, University College, Centre for Rheumatology ResearchRoom 118, 1st Floor, Windeyer Institute, 46 Cleveland Street, London W1T 4JF UK
    Expert Rev Clin Immunol 2:225-36. 2006
    ..By characterizing these mutations we can aim to define and target populations of pathogenic autoantibodies that cause autoimmune rheumatic diseases...
  9. ncbi request reprint Anti-DNA antibodies--overview of assays and clinical correlations
    A Rahman
    Centre for Rheumatology, Department of Medicine, University College London, London, UK
    Lupus 11:770-3. 2002
    ..In patients with SLE, reduced clearance of nucleosomes released from apoptotic cells may induce the formation of anti-nucleosome antibodies...
  10. pmc Cytokines in systemic lupus erythematosus, London, UK
    Anisur Rahman
    Centre for Rheumatology, Department of Medicine, University College London, London, UK
    Arthritis Res Ther 5:160-4. 2003
    ..A final discussion explored the possible ways in which cytokine modulation might lead to new methods of treating systemic lupus erythematosus in the future...
  11. ncbi request reprint Molecular expression systems for anti-DNA antibodies--1
    A Rahman
    Centre for Rheumatology, Department of Medicine, University College London, London, UK
    Lupus 11:824-32. 2002
    ..These motifs can be present on either the heavy or the light chain, but are particularly reported in V(H)CDR3...
  12. ncbi request reprint Systematic analysis of sequences of anti-DNA antibodies--relevance to theories of origin and pathogenicity
    A Rahman
    Centre for Rheumatology, London, UK
    Lupus 11:807-23. 2002
    ..Computer modeling and in-vitro expression experiments are likely to help define the roles played by these residues in antigen binding and pathogenicity more clearly...
  13. ncbi request reprint Anti-DNA antibodies--structure and function
    A Rahman
    Centre for Rheumatology, Department of Medicine, University College London, UK
    Lupus 11:776-9. 2002
    ..Some of these early plasma cells belong to clones that have rearranged the V(H) gene V4-34. There is a selective rise in immunoglobulins encoded by this gene in both infectious mononucleosis and SLE...
  14. ncbi request reprint Arginine residues are important in determining the binding of human monoclonal antiphospholipid antibodies to clinically relevant antigens
    Ian Giles
    Centre for Rheumatology, Department of Medicine, University College, London, UK
    J Immunol 177:1729-36. 2006
    ..We hypothesize that these four Arg residues have developed as a result of somatic mutations driven by an Ag containing both PL and beta2GPI...
  15. pmc The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin
    Ian Giles
    Centre for Rheumatology, Department of Medicine, University College London, UK
    Arthritis Res Ther 7:R47-56. 2005
    ..Subsets of arginine residues at specific locations in the CDRs of heavy chains and light chains of pathogenic antiphospholipid antibodies are important in determining their ability to bind CL...
  16. ncbi request reprint Arginine mutation alters binding of a human monoclonal antibody to antigens linked to systemic lupus erythematosus and the antiphospholipid syndrome
    Anastasia Lambrianides
    University College London, London, UK
    Arthritis Rheum 56:2392-401. 2007
    ..The present study was undertaken to investigate, using this expression system, the importance of the arginine residue at position 53 (R53) in B3 V(H)...
  17. pmc Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study
    Jessica J Manson
    Centre for Rheumatology Research, University College London, Windeyer Institute, 46 Cleveland Street, London W1T 4JF, UK
    Arthritis Res Ther 11:R154. 2009
    ..We assessed how well anti-alpha-actinin, anti-nucleosome and anti-double-stranded DNA (anti-dsDNA) antibodies reflected renal outcome measures in patients with new-onset LN followed for up to 2 years...
  18. pmc Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43
    Yiannis Ioannou
    University College London, London, UK
    Arthritis Rheum 56:280-90. 2007
    ..However, peptides homologous to other regions of domain I have also been shown to bind aPL. Furthermore, there are no published reports of the effects of altering R39, which has greater surface exposure than the G40-R43 residues...
  19. ncbi request reprint Somatic mutations to arginine residues affect the binding of human monoclonal antibodies to DNA, histones, SmD and Ro antigen
    Joanna Haley
    Centre for Rheumatology Bloomsbury Rheumatology Unit, Division of Medicine, University College, London, UK
    Mol Immunol 40:745-58. 2004
    ....
  20. pmc A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli
    Yiannis Ioannou
    Centre for Rheumatology, Department of Medicine, University College London, Arthur Stanley House, 40 50 Tottenham Street, London, W1T 4NJ, UK
    BMC Biotechnol 6:8. 2006
    ..Expressing this protein in bacteria could facilitate studies investigating how this molecule interacts with aPL...
  21. doi request reprint Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus
    Sean G O'Neill
    University College London, London, UK
    Arthritis Rheum 62:845-54. 2010
    ..We undertook this study to examine whether levels of these antibodies rise in association with increased SLE disease activity...
  22. pmc Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity
    Lesley J Mason
    Centre for Rheumatology, Division of Medicine, University College London, UK
    Arthritis Res Ther 7:R971-83. 2005
    ..Sequence changes may alter the pathogenicity of B3, but further studies using different techniques are needed to investigate this possibility...
  23. doi request reprint Endothelial microparticle release is stimulated in vitro by purified IgG from patients with the antiphospholipid syndrome
    Charis Pericleous
    Centre for Rheumatology, Division of Medicine University College London, Rayne Institute, 4 th Floor, Room 422, 5 University Street, London
    Thromb Haemost 109:72-8. 2013
    ..3.4% ± 2.0 for HC IgG, p=0.0172). This study therefore demonstrates that purified polyclonal APS-IgG can drive EMP release. We propose that EMP generation may be a useful measure of aPL-mediated pathogenic effects upon EC...
  24. doi request reprint Systemic lupus erythematosus
    Anisur Rahman
    Centre for Rheumatology Research, Division of Medicine, University College London, London, United Kingdom
    N Engl J Med 358:929-39. 2008
  25. pmc Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies
    Charis Pericleous
    Centre for Rheumatology, Division of Medicine, University College London, London WC1E 6JF, UK
    Mol Immunol 49:56-63. 2011
    ..Both the strength of binding to DI and the ability to discriminate different DI variants varies between the different IgG antibodies tested. There was no simple relationship between these binding properties and antibody pathogenicity...
  26. ncbi request reprint Relative importance of different human aPL derived heavy and light chains in the binding of aPL to cardiolipin
    Ian P Giles
    Department of Medicine, Centre for Rheumatology, University College London, Arthur Stanley House, 40 50 Tottenham Street, London W1T 4NJ, UK
    Mol Immunol 40:49-60. 2003
    ....
  27. ncbi request reprint Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?
    Lesley J Mason
    Department of Medicine, University College London, London, UK
    Arthritis Rheum 50:866-70. 2004
    ..Both human monoclonal anti-DNA antibodies and antibodies affinity purified from the sera of patients with systemic lupus erythematosus (SLE) were investigated...
  28. pmc Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways
    Anastasia Lambrianides
    Medical Molecular Biology Unit, Institute of Child Health, Department of Medicine, Centre for Rheumatology Research, University College London, London, UK
    J Immunol 184:6622-8. 2010
    ....
  29. pmc Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis
    Anastasia Lambrianides
    University College London, London, UK
    Arthritis Rheum 63:3512-21. 2011
    ..To characterize the interaction between procoagulant and/or anticoagulant serine proteases and human monoclonal IgG antiphospholipid antibodies (aPL) and polyclonal IgG derived from patients with the antiphospholipid syndrome (APS)...
  30. pmc Systemic lupus erythematosus
    Jessica J Manson
    Centre for Rheumatology Research, Windeyer Building, University College London, 46 Cleveland Street, London W1T 4JF, UK
    Orphanet J Rare Dis 1:6. 2006
    ..Despite enormous improvements in prognosis since the introduction of corticosteroids and immunosuppressive drugs, SLE continues to have a significant impact on the mortality and morbidity of those affected...
  31. doi request reprint Thrombin binding predicts the effects of sequence changes in a human monoclonal antiphospholipid antibody on its in vivo biologic actions
    Ian Giles
    Department of Medicine, Centre for Rheumatology, Institute of Child Health, University College, London, United Kingdom
    J Immunol 182:4836-43. 2009
    ..However, this finding did not hold true for the effects of these IgG on activation of cultured endothelial cells in vitro, where there was a less clear relationship between binding properties and biologic effects...
  32. doi request reprint Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosus
    Sean G O'Neill
    Centre for Rheumatology Research, Division of Medicine, University College London, London, UK
    Rheumatology (Oxford) 48:573-5. 2009
    ..To develop a strategy for stratifying risk of cardiovascular disease (CVD) in a cohort of patients with SLE and to test the usefulness of this strategy in rationalizing management of cardiovascular risk factors...
  33. ncbi request reprint How do antiphospholipid antibodies bind beta2-glycoprotein I?
    Ian P Giles
    Centre for Rheumatology, University College London, 4th Floor Arthur Stanley House, 40 50 Tottenham Street, London W1T 4NJ, UK
    Arthritis Rheum 48:2111-21. 2003
  34. pmc Prevalence and impact of chronic widespread pain in the Bangladeshi and White populations of Tower Hamlets, East London
    Yasmin Choudhury
    Barts and the London School of Medicine and Dentistry, Centre for Primary Care and Public Health, 58 Turner Street, London, E1 2AB, UK
    Clin Rheumatol 32:1375-82. 2013
    ..Chronic pain is commoner and, of greater severity, in Bangladeshis than in Whites. On most measures in this study, British Bangladeshis resembled the Whites more than the Bangladeshis. ..
  35. doi request reprint How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive
    Ian Giles
    Centre for Rheumatology Research, UCL Division of Medicine, University College London, 46 Cleveland Street, London, United Kingdom
    Best Pract Res Clin Rheumatol 23:525-37. 2009
    ..However, these treatments are not ideal as they can have major side effects such as haemorrhage. Research which may lead to better, more targeted therapy for APS is discussed at the end of the article...
  36. doi request reprint Examining how antiphospholipid antibodies activate intracellular signaling pathways: a systematic review
    Katie Poulton
    Centre for Rheumatology Research, Division of Medicine, University College London, London, UK
    Semin Arthritis Rheum 41:720-36. 2012
    ..We therefore undertook a systematic review of the literature to provide a critical analysis of the strength of the evidence that specific receptors and signaling pathways are important in the pathogenesis of antiphospholipid syndrome...
  37. ncbi request reprint Systemic lupus erythematosus--2005 annus mirabilis?
    David Isenberg
    Center for Rheumatology, University College London Hospitals, London, UK
    Nat Clin Pract Rheumatol 2:145-52. 2006
    ..This wolf might not yet be about to become extinct but its survival is increasingly under threat!..
  38. ncbi request reprint Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study
    Rupa Bessant
    University College London, London, UK
    Arthritis Rheum 55:892-9. 2006
    ..We compared the prevalence of conventional and lupus-specific risk factors in patients with SLE just before a cardiovascular event and in matched controls with SLE but no cardiovascular disease (CVD)...
  39. doi request reprint Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years
    Sharon A Chambers
    Department of Medicine, The Centre for Rheumatology, University College London, London, UK
    Rheumatology (Oxford) 48:673-5. 2009
    ..To study damage accrual and mortality in British patients with SLE under long-term follow-up for >10 years...
  40. doi request reprint The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluation
    Tabitha Turner-Stokes
    Centre for Rheumatology Research, University College Hospital, London, UK
    Rheumatology (Oxford) 50:1401-8. 2011
    ..The aims of the study were to: (i) assess the efficacy and safety of repeated cycles of BCDT in treating refractory SLE; and (ii) assess whether retreatment produced a more sustained clinical response...
  41. doi request reprint Introduction to a systemic lupus erythematosus - biomarkers meeting held at University College London on 23rd and 24th February 2007
    David Isenberg
    Department of Medicine, Centre for Rheumatology, University College London, London, UK
    Lupus 17:231. 2008
  42. doi request reprint Impaired C3b/iC3b deposition on Streptococcus pneumoniae in serum from patients with systemic lupus erythematosus
    Fiona Goldblatt
    Department of Medicine, Centre for Rheumatology, University College London Hospital, Rayne Institute, London, UK
    Rheumatology (Oxford) 48:1498-501. 2009
    ..To determine whether opsonization of Streptococcus pneumoniae with C3b/iC3b is impaired in serum from patients with SLE...
  43. doi request reprint Systemic lupus erythematosus in 2013. Taking a closer look at biologic therapy for SLE
    David A Isenberg
    Centre for Rheumatology, University College London, Room 424, 4th Floor Rayne Building, 5 University Street, London WC1E 6JF, UK
    Nat Rev Rheumatol 10:71-2. 2014
    ..2013 has seen the publication of some potentially landmark papers, which not only explore the potential of novel agents but also glean new insights from past trials...
  44. pmc Imaging assessment of cardiovascular disease in systemic lupus erythematosus
    Sara C Croca
    Centre for Rheumatology, Division of Medicine, University College London, London WC1E 6JF, UK
    Clin Dev Immunol 2012:694143. 2012
    ..This review will focus on the current status of the imaging tools available to assess cardiac and vascular function in patients with SLE...
  45. ncbi request reprint A systematic analysis of sequences of human antiphospholipid and anti-beta2-glycoprotein I antibodies: the importance of somatic mutations and certain sequence motifs
    Ian P Giles
    Department of Medicine, Centre for Rheumatology, University College London, London, England
    Semin Arthritis Rheum 32:246-65. 2003
    ..The authors tested this hypothesis by carrying out a systematic analysis of all published aPL sequences...
  46. ncbi request reprint Common patterns of B cell perturbation and expanded V4-34 immunoglobulin gene usage in autoimmunity and infection
    C Ian Mockridge
    Molecular Immunology Group, Tenovus Laboratory, Southampton University Hospitals Trust, Tremona Road, Southampton SO16 6YD, UK
    Autoimmunity 37:9-15. 2004
    ..If so, censoring is bypassed following EBV infection, after which equilibrium is restored. Continuing high serum levels in SLE may arise either by disordered regulation, or by subclinical reactivation of endogenous virus...
  47. ncbi request reprint Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity
    Chee Seng Yee
    University of Birmingham, Birmingham, UK
    Arthritis Rheum 54:3300-5. 2006
    ..To test the interrater reliability of the revised British Isles Lupus Assessment Group 2004 (BILAG-2004) index for the assessment of systemic lupus erythematosus (SLE) activity...
  48. pmc British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus
    Chee Seng Yee
    Department of Rheumatology, Division of Infection and Immunity, Medical School, University of Birmingham, Birmingham, UK
    Arthritis Rheum 56:4113-9. 2007
    ..To determine the construct and criterion validity of the British Isles Lupus Assessment Group 2004 (BILAG-2004) index for assessing disease activity in systemic lupus erythematosus (SLE)...
  49. ncbi request reprint Molecular and genetic characterizations of five pathogenic and two non-pathogenic monoclonal antiphospholipid antibodies
    Reginald U Chukwuocha
    Department of Medicine, Division of Rheumatology, University of California, Los Angeles, 32 59 Rehabilitation Center, 1000 Veteran Avenue, Los Angeles, CA 90095 1670, USA
    Mol Immunol 39:299-311. 2002
    ..The increased accumulation of arginine residues in the V(H) CDR3 may act to enhance antigen binding, promote disease and point to the importance of the H chain in the pathogenic potential of certain antiphospholipid antibodies...
  50. pmc Could antibodies to C-reactive protein link inflammation and cardiovascular disease in patients with systemic lupus erythematosus?
    Sean G O'Neill
    Ann Rheum Dis 66:989-91. 2007
  51. ncbi request reprint "It struck me that they didn't understand pain": the specialist pain clinic experience of patients with chronic musculoskeletal pain
    Geoffrey Harding
    Peninsula Medical School, Universities of Exeter and Plymouth, UK
    Arthritis Rheum 53:691-6. 2005
    ..To explore the experiences of diagnosis and management among patients who attended a specialist musculoskeletal pain clinic and the factors influencing their interpretation of these experiences...
  52. ncbi request reprint Validation of MSAT: an instrument to measure medical students' self-assessed confidence in musculoskeletal examination skills
    Pirashanthie Vivekananda-Schmidt
    Primary Care Sciences Research Centre, Keele University, Keele, UK
    Med Educ 41:402-10. 2007
    ..We present a new musculoskeletal self-assessment tool (MSAT) that allows students to assess their confidence in their skills in and knowledge of knee and shoulder examination...
  53. ncbi request reprint Acupuncture in the treatment of fibromyalgia in tertiary care--a case series
    Barbara Duncan
    Pain Management Centre, The National Hospital for Neurology and Neurosurgery University College, London Hospitals, UK
    Acupunct Med 25:137-47. 2007
    ..Many patients seek acupuncture treatment, which is reported to be helpful in some cases. This study aimed to explore the acceptability and benefits of acupuncture offered in the setting of a tertiary referral clinic...
  54. ncbi request reprint Management of cardiovascular risk factors in patients with systemic lupus erythematosus
    Anisur Rahman
    Acta Reumatol Port 33:13-5. 2008
  55. doi request reprint Stem cells and enhanced healing of chronic tympanic membrane perforation
    Anisur Rahman
    Department of Otorhinolaryngology, Karolinska Institute Karolinska University Hospital, Stockholm, Sweden
    Acta Otolaryngol 128:352-9. 2008
    ..This provides a basis for the exploration of stem cell treatment for TM perforations and holds promise for future improvements...
  56. ncbi request reprint Healing time, long-term result and effects of stem cell treatment in acute tympanic membrane perforation
    Anisur Rahman
    Center for Hearing and Communication Research, Department of Otorhinolaryngology, Karolinska University Hospital and Institute, 17176 Stockholm, Sweden
    Int J Pediatr Otorhinolaryngol 71:1129-37. 2007
    ..The possibility of teratogenic effects of the stem cells was also observed...